FI831740A0 - Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt - Google Patents

Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt

Info

Publication number
FI831740A0
FI831740A0 FI831740A FI831740A FI831740A0 FI 831740 A0 FI831740 A0 FI 831740A0 FI 831740 A FI831740 A FI 831740A FI 831740 A FI831740 A FI 831740A FI 831740 A0 FI831740 A0 FI 831740A0
Authority
FI
Finland
Prior art keywords
framework
seskviterpenlaktonhaltigt
etces
pharmaceutical extract
pharmaceutical
Prior art date
Application number
FI831740A
Other languages
English (en)
Other versions
FI831740L (fi
Inventor
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Original Assignee
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26282867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI831740(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edward Stewart Johnson, Peter John Hylands, Deborah Margaret Hylands filed Critical Edward Stewart Johnson
Publication of FI831740A0 publication Critical patent/FI831740A0/fi
Publication of FI831740L publication Critical patent/FI831740L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI831740A 1982-05-19 1983-05-18 Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt FI831740L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8214572 1982-05-19
GB8227062 1982-09-22

Publications (2)

Publication Number Publication Date
FI831740A0 true FI831740A0 (fi) 1983-05-18
FI831740L FI831740L (fi) 1983-11-20

Family

ID=26282867

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831740A FI831740L (fi) 1982-05-19 1983-05-18 Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt

Country Status (13)

Country Link
US (1) US4758433A (fi)
EP (1) EP0098041B1 (fi)
KR (1) KR840004511A (fi)
AR (1) AR230008A1 (fi)
AU (1) AU564371B2 (fi)
CA (1) CA1270843A (fi)
DE (1) DE3380306D1 (fi)
DK (1) DK219083A (fi)
FI (1) FI831740L (fi)
GB (1) GB2124486B (fi)
IE (1) IE55766B1 (fi)
NO (1) NO831762L (fi)
NZ (1) NZ204256A (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
MC2056A1 (fr) * 1987-12-23 1990-09-04 Psoricur Ltd Composition therapeutique contre le psoriasis,procede pour sa preparation et utilisation de plantes medicinales qu'elle contient
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
US5576329A (en) * 1992-07-24 1996-11-19 Hennessey; Richard K. Method for treating tendon or joint inflammation with papaverine HCL
US5278172A (en) * 1992-07-24 1994-01-11 Hennessey Richard K Method and composition for treating tendon or joint inflammation using a vasodilator
CN1056142C (zh) * 1993-01-04 2000-09-06 昆明医学院第一附属医院 水朝阳内酯的制备方法
CA2141126A1 (en) * 1995-01-26 1996-07-27 Natalie J. Lazarowych Combinational drug for treating migraine and other illnesses
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
ES2172006T3 (es) * 1996-10-21 2002-09-16 Eurovita As Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium.
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
WO1999033463A1 (en) * 1997-12-23 1999-07-08 Moser, René SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b)
US6225339B1 (en) 1998-01-29 2001-05-01 Pfizer Inc. Terpenoid lactone compounds and their production process
US6068999A (en) 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
US6221899B1 (en) 1999-01-15 2001-04-24 Pfizer Inc. Terpenoid lactone compounds and their production process
ATE291433T1 (de) * 1999-06-03 2005-04-15 Johnson & Johnson Consumer Fr Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
IT1312342B1 (it) 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US6642243B1 (en) 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
DE10015617A1 (de) * 2000-03-29 2001-10-04 Peter Laetzsch Migränemittel
IN188857B (fi) * 2000-07-14 2002-11-16 Govind Kane Dr Shantaram
BRPI0208123B1 (pt) * 2001-03-16 2020-11-10 Johnson & Johnson método de melhorar a firmeza ou elasticidade de ou para retardar o processo de formação de linha fina ou ruga na pele
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
EP2170324A4 (en) * 2007-06-21 2010-11-03 Puramed Bioscience Inc COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MIGRAINE HEADACHE AND ASSOCIATED SYMPTOMS
US10500182B2 (en) * 2018-01-10 2019-12-10 Robert Firger Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache
CN109761994B (zh) * 2019-02-28 2021-06-29 中国科学院新疆理化技术研究所 降碳类愈创木烷型倍半萜内酯类化合物及其制备方法

Also Published As

Publication number Publication date
GB2124486B (en) 1986-07-16
US4758433A (en) 1988-07-19
CA1270843A (en) 1990-06-26
DE3380306D1 (en) 1989-09-07
EP0098041A2 (en) 1984-01-11
FI831740L (fi) 1983-11-20
DK219083A (da) 1983-11-20
GB2124486A (en) 1984-02-22
GB8313530D0 (en) 1983-06-22
DK219083D0 (da) 1983-05-17
AU564371B2 (en) 1987-08-13
AR230008A1 (es) 1984-02-29
NZ204256A (en) 1988-02-29
EP0098041A3 (en) 1984-12-12
IE831164L (en) 1983-11-19
NO831762L (no) 1983-11-21
KR840004511A (ko) 1984-10-22
IE55766B1 (en) 1991-01-16
EP0098041B1 (en) 1989-08-02
AU1464683A (en) 1983-11-24

Similar Documents

Publication Publication Date Title
FI831740L (fi) Foerfarande foer framstaellning av ett seskviterpenlaktonhaltigt farmaceutiskt extrakt
FI833020A0 (fi) Foerfarande foer framstaellning av limtejp
FI811745L (fi) Farmaceutisk komposition och foerfarande foer framstaellning daerav
DK68392A (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
FI830285A0 (fi) Foerfarande foer blandning av ett aemne med ett annat aemne
FI813279L (fi) Foerfarande foer framstaellning av azabicyklo-oktan-karbolxylsyror
FI831534L (fi) Oxikam-derivat innehaollande farmaceutiska kompositioner och deras framstaellningsfoerfarande
FI822857A0 (fi) Foerfarande och anordning foer framstaellning av en faergkilfolie
NO168745C (no) Fremgangsmaate for fremstilling av farmasoeytisk blandingspreparat
IT1162879B (it) Composizioni farmaceutiche
FI834735A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
FI812708L (fi) Farmaceutiska blandningar foer fraemjande av laekning av saor
FI810056L (fi) Farmaceutiska foereningar
FI821910A0 (fi) Anordning foer delning av stroemningar
FI831148A0 (fi) Foerfarande foer framstaellning av substituerade penemderivat
RO88128A (ro) Procedeu pentru prepararea n-fosfanometilglicinei
FI832173A0 (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart pyrazolopyridinderivat
FI831687A0 (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
FI834736A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyridinderivat
FI831914L (fi) Foerfaranden foer framstaellning av pyrimidinoner och deras syraadditionssalt
IS2626A7 (is) Aðferð til framleiðslu á lyfjablöndum
FI821851A0 (fi) Anordning foer foerdelning av sidobraedorna i ett saogverk
FI821340A0 (fi) Foerfarande och anordning foer framstaellning av ett byggnadselement av betong
FI800481A (fi) Foerfarande foer framstaellning av substituerade acylpiperidiner
FI820999L (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara kefalosporinderivat

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: R.P.SCHERER CORPORATION